PT3283058T - Comprimido de ribociclib - Google Patents

Comprimido de ribociclib

Info

Publication number: PT3283058T
Authority: PT; Portugal
Prior art keywords: ribociclib; tablet; ribociclib tablet
Prior art date: 2015-04-16

Application number

PT167180207T

Other languages

English (en)

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-04-16

Filing date

2016-04-14

Publication date

2023-02-03

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55806565&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3283058(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2016-04-14 Application filed by Novartis Ag filed Critical Novartis Ag

2023-02-03 Publication of PT3283058T publication Critical patent/PT3283058T/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PT167180207T 2015-04-16 2016-04-14 Comprimido de ribociclib PT3283058T (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201562148240P	2015-04-16	2015-04-16

Publications (1)

Publication Number	Publication Date
PT3283058T true PT3283058T (pt)	2023-02-03

Family

ID=55806565

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT167180207T PT3283058T (pt)	2015-04-16	2016-04-14	Comprimido de ribociclib

Country Status (29)

Country	Link
US (6)	US10799506B2 (pt)
EP (3)	EP4620458A3 (pt)
JP (1)	JP2018514523A (pt)
KR (2)	KR20250009572A (pt)
CN (2)	CN115554257A (pt)
AR (1)	AR104257A1 (pt)
AU (5)	AU2016248017A1 (pt)
BR (1)	BR112017021283A2 (pt)
CA (1)	CA2982425C (pt)
CL (1)	CL2017002593A1 (pt)
CO (1)	CO2017010510A2 (pt)
DK (1)	DK3283058T3 (pt)
EA (1)	EA201792290A1 (pt)
EC (1)	ECSP17075052A (pt)
ES (1)	ES2938261T3 (pt)
FI (1)	FI3283058T3 (pt)
HR (1)	HRP20230053T1 (pt)
HU (1)	HUE061213T2 (pt)
IL (1)	IL254818A0 (pt)
MX (1)	MX2017013350A (pt)
PE (1)	PE20180035A1 (pt)
PH (1)	PH12017501820A1 (pt)
PL (1)	PL3283058T3 (pt)
PT (1)	PT3283058T (pt)
SG (1)	SG11201708084PA (pt)
SI (1)	SI3283058T1 (pt)
TN (1)	TN2017000422A1 (pt)
TW (1)	TW201642864A (pt)
WO (1)	WO2016166703A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI3283058T1 (sl)	2015-04-16	2023-03-31	Novartis Ag	Tableta ribocikliba
CA3048036A1 (en)	2018-07-02	2020-01-02	Apotex Inc	Novel crystalline form of ribociclib succinate
MX2022002415A (es)	2019-08-26	2022-03-22	Arvinas Operations Inc	Metodos de tratamiento del cancer de mama con derivados de tetrahidronaftaleno como degradadores del receptor de estrogenos.
IL293940A (en)	2019-12-16	2022-08-01	Lunella Biotech Inc	Selective cancer drugs cdk4/6 inhibitors
CN118652252A (zh)	2019-12-16	2024-09-17	卢内拉生物技术有限公司	选择性cdk4/6抑制剂型癌症治疗药物
BR112023001454A2 (pt) *	2020-08-03	2023-02-14	Natco Pharma Ltd	Composição de comprimido de liberação imediata e processo para a preparação da composição
BR112023005247A2 (pt) *	2020-09-29	2023-04-25	Laboratorios Silanes S A De C V	Combinações farmacêuticas de estatinas e fibratos para o tratamento e prevenção da hiperlipidemia e doenças cardiovasculares
WO2022162122A1 (en)	2021-01-29	2022-08-04	Biotx.Ai Gmbh	Genetically verified netosis inhibitor for use in the treatment of a sars-cov2 infection
TWI848533B (zh)	2022-01-25	2024-07-11	瑞士商諾華公司	瑞博西尼藥物組成物
TWI866427B (zh)	2022-08-31	2024-12-11	美商亞文納營運公司	雌激素受體降解劑之給藥方案
EP4626890A1 (en)	2022-12-01	2025-10-08	KRKA, d.d., Novo mesto	Ribociclib salts and formulations thereof
TW202440113A (zh)	2023-03-27	2024-10-16	瑞士商諾華公司	治療早期乳癌之方法
US20250319032A1 (en)	2024-04-15	2025-10-16	Novartis Ag	Pharmaceutical compositions of ribociclib

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5428812A (en) *	1977-08-09	1979-03-03	Yoshitomi Pharmaceut Ind Ltd	Preparation of coated tablet
GB9414045D0 (en)	1994-07-12	1994-08-31	Berwind Pharma Service	Moisture barrier film coating composition, method, and coated form
EP0771339B1 (en) *	1994-07-12	2003-10-15	BPSI Holdings, Inc.	Dry moisture barrier film coating composition, method of coating substrates using the same and pharmaceutical tablets coated therewith
US6448323B1 (en) *	1999-07-09	2002-09-10	Bpsi Holdings, Inc.	Film coatings and film coating compositions based on polyvinyl alcohol
BRPI0917791B1 (pt)	2008-08-22	2022-03-22	Novartis Ag	Compostos de pirrolopirimidina como inibidores de cdk, bem como composição farmacêutica e combinação
US20110070301A1 (en) *	2009-09-24	2011-03-24	Luber Joseph R	Orally transformable tablets
AR083797A1 (es) *	2010-11-10	2013-03-20	Novartis Ag	Succinato de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]pirimidin-6-carboxilico, proceso para prepararla, intermediarios de dicha sintesis y proceso de preparacion de los mismos
CA2827027C (en) *	2011-02-11	2019-06-04	Wista Laboratories Ltd.	Phenothiazine diaminium salts and their use
CN110840870A (zh) *	2012-07-13	2020-02-28	Gtx公司	选择性雄激素受体调节剂在治疗转移性和难治性乳癌中的应用
EP3251673A1 (en)	2012-12-13	2017-12-06	IP Gesellschaft für Management mbH	Combination therapy comprising a cdk4/6 inhibitor and a pi3k inhibitor for use in the treatment of cancer
EP2934515B1 (en) *	2012-12-20	2018-04-04	Novartis AG	A pharmaceutical combination comprising binimetinib
SG11201507730UA (en) *	2013-03-21	2015-10-29	Novartis Ag	Combination therapy comprising a b-raf inhibitor and a second inhibitor
EP2810644A1 (en) *	2013-06-06	2014-12-10	Ferrer Internacional, S.A.	Oral formulation for the treatment of cardiovascular diseases
SI3283058T1 (sl) *	2015-04-16	2023-03-31	Novartis Ag	Tableta ribocikliba
CN109953966A (zh) *	2017-12-26	2019-07-02	天津耀辰实业发展有限公司	一种含有瑞博西尼的药物组合物及其制备方法
JP7347388B2 (ja)	2020-09-25	2023-09-20	信越化学工業株式会社	紫外線硬化型有機変性シリコーン組成物および硬化物

2016
- 2016-04-14 SI SI201631661T patent/SI3283058T1/sl unknown
- 2016-04-14 CN CN202211237232.XA patent/CN115554257A/zh active Pending
- 2016-04-14 DK DK16718020.7T patent/DK3283058T3/da active
- 2016-04-14 ES ES16718020T patent/ES2938261T3/es active Active
- 2016-04-14 EP EP25194967.3A patent/EP4620458A3/en active Pending
- 2016-04-14 CA CA2982425A patent/CA2982425C/en active Active
- 2016-04-14 EP EP22203730.1A patent/EP4197530B1/en active Active
- 2016-04-14 FI FIEP16718020.7T patent/FI3283058T3/fi active
- 2016-04-14 PL PL16718020.7T patent/PL3283058T3/pl unknown
- 2016-04-14 EA EA201792290A patent/EA201792290A1/ru unknown
- 2016-04-14 KR KR1020257000051A patent/KR20250009572A/ko active Pending
- 2016-04-14 PE PE2017002096A patent/PE20180035A1/es unknown
- 2016-04-14 MX MX2017013350A patent/MX2017013350A/es unknown
- 2016-04-14 CN CN201680022122.8A patent/CN107530292B/zh active Active
- 2016-04-14 BR BR112017021283A patent/BR112017021283A2/pt not_active Application Discontinuation
- 2016-04-14 EP EP16718020.7A patent/EP3283058B1/en active Active
- 2016-04-14 HR HRP20230053TT patent/HRP20230053T1/hr unknown
- 2016-04-14 JP JP2017553915A patent/JP2018514523A/ja active Pending
- 2016-04-14 WO PCT/IB2016/052136 patent/WO2016166703A1/en not_active Ceased
- 2016-04-14 TN TNP/2017/000422A patent/TN2017000422A1/en unknown
- 2016-04-14 PT PT167180207T patent/PT3283058T/pt unknown
- 2016-04-14 HU HUE16718020A patent/HUE061213T2/hu unknown
- 2016-04-14 AU AU2016248017A patent/AU2016248017A1/en not_active Abandoned
- 2016-04-14 KR KR1020177029433A patent/KR102750931B1/ko active Active
- 2016-04-14 US US15/564,534 patent/US10799506B2/en active Active
- 2016-04-14 SG SG11201708084PA patent/SG11201708084PA/en unknown
- 2016-04-14 AR ARP160101012A patent/AR104257A1/es unknown
- 2016-04-15 TW TW105111921A patent/TW201642864A/zh unknown
2017
- 2017-10-01 IL IL254818A patent/IL254818A0/en unknown
- 2017-10-04 PH PH12017501820A patent/PH12017501820A1/en unknown
- 2017-10-13 CL CL2017002593A patent/CL2017002593A1/es unknown
- 2017-10-13 CO CONC2017/0010510A patent/CO2017010510A2/es unknown
- 2017-11-10 EC ECIEPI201775052A patent/ECSP17075052A/es unknown
2019
- 2019-03-20 AU AU2019201929A patent/AU2019201929B2/en active Active
2020
- 2020-08-26 US US17/003,771 patent/US20200390771A1/en not_active Abandoned
- 2020-10-06 AU AU2020250190A patent/AU2020250190A1/en not_active Abandoned
2022
- 2022-06-08 US US17/805,956 patent/US12064434B2/en active Active
- 2022-08-08 AU AU2022215155A patent/AU2022215155B2/en active Active
2024
- 2024-02-27 US US18/588,259 patent/US20250090531A1/en active Pending
- 2024-10-31 AU AU2024227794A patent/AU2024227794A1/en active Pending
- 2024-12-11 US US18/977,210 patent/US20250134893A1/en active Pending
- 2024-12-11 US US18/977,228 patent/US12419894B2/en active Active

Also Published As

Publication number	Publication date
AU2022215155B2 (en)	2024-08-01
EP4620458A2 (en)	2025-09-24
US12064434B2 (en)	2024-08-20
HUE061213T2 (hu)	2023-05-28
AU2016248017A1 (en)	2017-10-19
TW201642864A (zh)	2016-12-16
PL3283058T3 (pl)	2023-03-20
CN107530292B (zh)	2022-11-01
PH12017501820A1 (en)	2018-04-23
EP4197530B1 (en)	2025-11-12
CN107530292A (zh)	2018-01-02
EP4620458A3 (en)	2025-10-22
EA201792290A1 (ru)	2018-02-28
IL254818A0 (en)	2017-12-31
US20250134893A1 (en)	2025-05-01
EP3283058A1 (en)	2018-02-21
CA2982425A1 (en)	2016-10-20
US20230104792A1 (en)	2023-04-06
US20250090531A1 (en)	2025-03-20
US20200390771A1 (en)	2020-12-17
BR112017021283A2 (pt)	2018-06-26
KR20250009572A (ko)	2025-01-17
PE20180035A1 (es)	2018-01-09
US12419894B2 (en)	2025-09-23
US20180071292A1 (en)	2018-03-15
JP2018514523A (ja)	2018-06-07
FI3283058T3 (fi)	2023-03-01
CL2017002593A1 (es)	2018-05-18
AR104257A1 (es)	2017-07-05
AU2022215155A1 (en)	2022-09-01
HRP20230053T1 (hr)	2023-03-03
US10799506B2 (en)	2020-10-13
CA2982425C (en)	2023-10-31
SG11201708084PA (en)	2017-10-30
AU2020250190A1 (en)	2020-11-05
AU2019201929B2 (en)	2020-07-09
MX2017013350A (es)	2018-01-25
US20250127785A1 (en)	2025-04-24
ECSP17075052A (es)	2018-02-28
EP3283058B1 (en)	2022-11-16
KR102750931B1 (ko)	2025-01-09
AU2019201929A1 (en)	2019-04-11
SI3283058T1 (sl)	2023-03-31
TN2017000422A1 (en)	2019-01-16
EP4197530A1 (en)	2023-06-21
AU2024227794A1 (en)	2024-11-21
WO2016166703A1 (en)	2016-10-20
CO2017010510A2 (es)	2018-03-20
CN115554257A (zh)	2023-01-03
DK3283058T3 (da)	2023-02-13
KR20170137101A (ko)	2017-12-12
ES2938261T3 (es)	2023-04-05

Publication	Publication Date	Title
DK3256579T3 (en)	2023-11-20	Cysteinprotease
DK3256580T3 (en)	2022-10-03	Cysteinprotease
GB201707959D0 (en)	2017-07-05	No details
AU356804S (en)	2014-08-11	Tablet
DK3250592T3 (en)	2023-01-09	Anti-transthyretin-antistoffer
IL254818A0 (en)	2017-12-31	Ribociclib tablet
GB201706130D0 (en)	2017-05-31	No details
DK3284069T3 (en)	2022-09-26	Pos-terminal
SG10201914087UA (en)	2020-03-30	Tablet
GB201615071D0 (en)	2016-10-19	No details
GB201612542D0 (en)	2016-08-31	no details
DK3272750T3 (en)	2022-01-03	Morphinan-derivat
GB201709180D0 (en)	2017-07-26	No details
GB201420300D0 (en)	2014-12-31	Tablet
AU361999S (en)	2015-05-27	Ballustrade
GB201616225D0 (en)	2016-11-09	No details
DK3133099T3 (en)	2020-11-09	Polymermodificeret polyoldispersion
AU356801S (en)	2014-08-11	Tablet
DK3242882T3 (en)	2022-08-08	Cgrp-antagonistpeptider
GB201708207D0 (en)	2017-07-05	No details
DK3282866T3 (en)	2019-05-20	Proteinfibre
GB201511252D0 (en)	2015-08-12	Tablet
DK3250312T3 (en)	2020-09-28	Urea-metalnitrat-scr-system
DK3294653T3 (en)	2022-04-19	Justerbar inline-port
GB201702336D0 (en)	2017-03-29	No details